sulfasalazine has been researched along with Koch's Disease in 4 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Y | 1 |
| Yang, Q | 1 |
| Liao, M | 1 |
| Wang, H | 1 |
| Zhang, C | 1 |
| Nambi, S | 1 |
| Wang, W | 1 |
| Zhang, M | 1 |
| Wu, J | 1 |
| Deng, G | 1 |
| Deng, Q | 1 |
| Liu, H | 1 |
| Zhou, B | 1 |
| Jin, Q | 1 |
| Feng, CG | 1 |
| Sassetti, CM | 1 |
| Wang, F | 1 |
| Chen, X | 1 |
| Vanhoof, J | 1 |
| Landewe, S | 1 |
| Van Wijngaerden, E | 1 |
| Geusens, P | 1 |
| Yokogawa, K | 1 |
| Nakaharu, T | 1 |
| Ishizaki, J | 1 |
| Ozaki, E | 1 |
| Takeda, Y | 1 |
| Mabuchi, H | 1 |
| Matsushita, R | 1 |
| Kimura, K | 1 |
| Nakashima, E | 1 |
| Ichimura, F | 1 |
| Miyamoto, K | 1 |
| Butt, JH | 1 |
1 review available for sulfasalazine and Koch's Disease
| Article | Year |
|---|---|
Outpatient management of inflammatory bowel disease. Let's keep it as simple as possible.
Topics: Abdominal Pain; Adrenal Cortex Hormones; Ambulatory Care; Aminosalicylic Acids; Anus Diseases; Diarr | 1992 |
1 trial available for sulfasalazine and Koch's Disease
| Article | Year |
|---|---|
Kinetic phenotypic diagnosis of N-acetylation polymorphism in patients based on ratio of urinary metabolites of salicylazosulfapyridine.
Topics: Acetylation; Adult; Aminosalicylic Acids; Biotransformation; DNA; Genotype; Humans; Models, Biologic | 2001 |
2 other studies available for sulfasalazine and Koch's Disease
| Article | Year |
|---|---|
xCT increases tuberculosis susceptibility by regulating antimicrobial function and inflammation.
Topics: Amino Acid Transport System y+; Animals; Anti-Infective Agents; Case-Control Studies; Cell Line, Tum | 2016 |
High incidence of hepatotoxicity of isoniazid treatment for tuberculosis chemoprophylaxis in patients with rheumatoid arthritis treated with methotrexate or sulfasalazine and anti-tumour necrosis factor inhibitors.
Topics: Adult; Aged; Antirheumatic Agents; Antitubercular Agents; Arthritis, Rheumatoid; Chemical and Drug I | 2003 |